Related Experiment Video
Updated: Aug 2, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Low-molecular-weight heparin in preventing and treating DVT
E J Rydberg1, J M Westfall, R A Nicholas
1University of Colorado Health Sciences Center, Denver, USA.
American Family Physician
|April 8, 1999
Summary
Low-molecular-weight heparin offers effective prophylaxis and treatment for deep venous thrombosis (DVT). This therapy allows for outpatient treatment, reducing hospitalizations without increasing risks of recurrent thromboembolism or bleeding.
Area of Science:
- Pharmacology
- Vascular Medicine
- Thrombosis Research
Background:
- Deep venous thrombosis (DVT) traditionally required inpatient intravenous heparin treatment.
- Low-molecular-weight heparin (LMWH) has emerged as a significant therapeutic advancement.
Purpose of the Study:
- To evaluate the efficacy and safety of LMWH in DVT prophylaxis and treatment.
- To explore the potential for outpatient management of DVT using LMWH.
Main Methods:
- Comparative analysis of LMWH versus standard heparin and warfarin for DVT prophylaxis.
- Assessment of subcutaneous LMWH administration for DVT treatment in an outpatient setting.
Main Results:
- LMWH demonstrates equivalent prophylactic efficacy to standard heparin and warfarin.
- Outpatient DVT treatment with subcutaneous LMWH shows no increased risk of recurrent thromboembolism or bleeding.
- LMWH eliminates the need for routine monitoring of activated partial thromboplastin time or International Normalized Ratio.
Conclusions:
- LMWH is a safe and effective alternative for DVT prophylaxis and treatment.
- Subcutaneous LMWH facilitates outpatient management of DVT, improving patient convenience.
- LMWH is particularly suitable for first-time DVT episodes in patients without bleeding risks who can manage injections.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...